Company Monitoring Page for Merck

latest headlines for company on cafepharma

FDA Questions Efficacy of Merck-AstraZeneca’s Lynparza Ahead of Adcomm
BioSpace
Thu, 04/27/23 - 10:58 pm
Tags:
Merck, AstraZeneca, FDA, Lynparza, metastatic castration-resistant prostate cancer
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
Tags:
AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Gilead Sceinces, JNJ, Merck, Pfizer, Regeneron, patents, activists
Merck, Glenmark wrap up Zetia pay-for-delay case after pharmacies take settlement
Fierce Pharma
Tue, 04/25/23 - 10:05 pm
Tags:
Merck, Glenmark, Zetia, pay-for-delay, legal
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
Fierce Pharma
Fri, 04/21/23 - 10:20 am
Tags:
Merck, Glenmark, Zetia, pay-for-delay, antitrust, legal
Moderna and Merck’s mRNA Cancer Vaccine Impresses but Experts Urge Caution
BioSpace
Fri, 04/21/23 - 10:10 am
Tags:
Moderna Therapeutics, Merck, MRNA, cancer vaccines, vaccines
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D, AbbVie, Amgen, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, GSK, JNJ, Merck, Merck KGaA, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, UCB, Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
Tags:
M&A, R&D, AbbVie, AstraZeneca, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Tue, 04/18/23 - 10:10 pm
Tags:
Big Pharma, M&A, Merck, Prometheus Biosciences, GSK, Bellus Health
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off
Fierce Pharma
Mon, 04/17/23 - 10:49 pm
Tags:
Pfizer, Seagen, M&A, Merck
Merck’s latest deal turns up the spotlight on immune system drugmakers
BioPharma Dive
Mon, 04/17/23 - 10:47 pm
Tags:
Merck, M&A, Prometheus Biosciences, immunology
Moderna & Merck plan Phase 3 trial for cancer vaccine with Keytruda
Biopharma Reporter
Mon, 04/17/23 - 12:05 pm
Tags:
Merck, Moderna Therapeutics, cancer, cancer vaccines, Keytruda, clinical trials
Merck to buy inflammatory disease drugmaker Prometheus for $10.8B
BioPharma Dive
Sun, 04/16/23 - 11:31 pm
Tags:
Merck, M&A, Prometheus Biosciences, IBD
Trailing AstraZeneca and Merck, Junshi reports phase 3 ovarian cancer success for Lynparza rival
Fierce Biotech
Wed, 04/12/23 - 11:39 am
Tags:
Junshi Biosciences, PARP inhibitors, ovarian cancer, Merck, AstraZeneca, Lynparza
Court Orders Merck to Produce Entire Database of Gardasil Adverse Events
EIN Newswires
Mon, 04/10/23 - 05:02 pm
Tags:
legal, Merck, vaccines, Gardasil
Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine
Investors Business Daily
Mon, 04/10/23 - 04:51 pm
Tags:
Moderna Therapeutics, Merck, MRNA, cancer, vaccines, Europe, cancer vaccine
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail
BioSpace
Fri, 04/7/23 - 01:58 pm
Tags:
Merck, Keytruda, Eisai, Lenvima, melanoma, clinical trials, cancer, colorectal cancer
Proxygen, averaging a new collab every 10 months, sticks $2.5B molecular glue deal with Merck
Fierce Biotech
Wed, 04/5/23 - 10:09 am
Tags:
Merck, Proxygen, molecular glue, protein degradation
FDA Approves Keytruda/Padcev Combo in Advanced Urothelial Cancer
BioSpace
Tue, 04/4/23 - 12:35 pm
Tags:
Merck, Seagen, Astellas, Keytruda, Padcev, metastatic urothelial carcinoma, FDA
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA, AbbVie, Alvotech, Ascendis Pharma, Astellas, AstraZeneca, Biogen, Daiichi Sankyo, Eli Lilly, Ferring Pharmaceuticals, Hugel, Innoviva, Ionis Pharmaceuticals, Lundbeck, Merck, Novo Nordisk, Otsuka, Pfizer, Roche Seagen, Seres Therapeutics, Takeda, UCB, Vertex Pharmaceuticals
FDA grants full approval to Keytruda in tumor-agnostic setting
Endpoints
Thu, 03/30/23 - 10:59 pm
Tags:
Merck, Keytruda, tumor agnostic, solid tumors

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.